购物车
- 全部删除
- 您的购物车当前为空
Cladribine (2CdA) 是一种嘌呤核苷类似物,是具有口服活性的腺苷脱氨酶抑制剂。它能作为 DNA 合成的抑制剂,可阻断受损 DNA 的修复。它可抑制 DNA 甲基化,具有抗淋巴瘤活性,可研究血液恶性肿瘤和多发性硬化。
为众多的药物研发团队赋能,
让新药发现更简单!
Cladribine (2CdA) 是一种嘌呤核苷类似物,是具有口服活性的腺苷脱氨酶抑制剂。它能作为 DNA 合成的抑制剂,可阻断受损 DNA 的修复。它可抑制 DNA 甲基化,具有抗淋巴瘤活性,可研究血液恶性肿瘤和多发性硬化。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 289 | 现货 | |
50 mg | ¥ 996 | 现货 | |
100 mg | ¥ 1,692 | 现货 | |
200 mg | ¥ 2,538 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 327 | 现货 |
产品描述 | Cladribine (2CdA), an adenosine deaminase inhibitor, is utilized in the treatment of lymphoproliferative diseases. |
靶点活性 | Adenosine deaminase (U266 cells):2.43 μM, Adenosine deaminase (MM1.S cells):0.18 μM, Adenosine deaminase (RPMI8226 cells):0.75 μM |
体外活性 | 在成年斑马鱼中,腹腔注射Cladribine(0.7-3.5 mM ),能够抑制RBC ATP浓度水平. |
体内活性 | 在原代肥大细胞(MC)和MC系HMC-1中,Cladribine抑制细胞生长。在CD14 +单核细胞以及CD4 +和CD8 + T淋巴细胞中,Cladribine降低细胞迁移能力。在U266,RPMI8226和MM1.S细胞中,Cladribine以剂量依赖性方式抑制细胞增殖。 |
细胞实验 | The non-radioactive cell proliferation kit is used to determine cell viability. In brief, Human MM cell line U266, RPMI8226 and MM1.S are seeded onto 96-well plates with either 0.1 mL complete medium (5% FBS) as control, or 0.1 mL of the same medium containing a series of doses of cladribine, and incubated for 72 hours. After reading all wells at 490 nm with a micro-plate reader, the percentages of surviving cells from each group relative to controls, defined as 100% survival, are determined by reduction of MTS.(Only for Reference) |
别名 | 克拉屈滨, CldAdo, 2-chlorodeoxyadenosine, 2-Chloro-2′-deoxyadenosine, 2CdA |
分子量 | 285.69 |
分子式 | C10H12ClN5O3 |
CAS No. | 4291-63-8 |
Smiles | Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1 |
密度 | 2.03g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 55 mg/mL (192.52 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容